These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30674255)

  • 1. A Review of Preclinical Experiments Toward Targeting M2 Macrophages in Prostate Cancer.
    Seif F; Sharifi L; Khoshmirsafa M; Mojibi Y; Mohsenzadegan M
    Curr Drug Targets; 2019; 20(7):789-798. PubMed ID: 30674255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting.
    Sharifi L; Nowroozi MR; Amini E; Arami MK; Ayati M; Mohsenzadegan M
    Int Immunopharmacol; 2019 Nov; 76():105880. PubMed ID: 31522016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
    Gambardella V; Castillo J; Tarazona N; Gimeno-Valiente F; Martínez-Ciarpaglini C; Cabeza-Segura M; Roselló S; Roda D; Huerta M; Cervantes A; Fleitas T
    Cancer Treat Rev; 2020 Jun; 86():102015. PubMed ID: 32248000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor-associated macrophages for cancer immunotherapy.
    Shu Y; Cheng P
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acid-targeted cyclodextrin-based nanoparticles deliver CSF-1R siRNA and reprogram tumour-associated macrophages for immunotherapy of prostate cancer.
    Sun Y; Cronin MF; Mendonça MCP; Guo J; O'Driscoll CM
    Eur J Pharm Sci; 2023 Jun; 185():106427. PubMed ID: 36948408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse macrophages polarization in tumor microenvironment.
    Rhee I
    Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
    Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
    Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation.
    Yin Y; Huang X; Lynn KD; Thorpe PE
    Cancer Immunol Res; 2013 Oct; 1(4):256-68. PubMed ID: 24777853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer immunotherapy: where are we and where are we going?
    De Velasco MA; Uemura H
    Curr Opin Urol; 2018 Jan; 28(1):15-24. PubMed ID: 29095729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
    Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
    J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic polysaccharide spermine-pullulan drives tumor associated macrophage towards M1 phenotype to inhibit tumor progression.
    Xie L; Yang Y; Meng J; Wen T; Liu J; Xu H
    Int J Biol Macromol; 2019 Feb; 123():1012-1019. PubMed ID: 30439425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression.
    Comito G; Giannoni E; Segura CP; Barcellos-de-Souza P; Raspollini MR; Baroni G; Lanciotti M; Serni S; Chiarugi P
    Oncogene; 2014 May; 33(19):2423-31. PubMed ID: 23728338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy.
    Sun Y; Cronin MF; Mendonça MCP; Guo J; O'Driscoll CM
    Mol Pharm; 2023 Nov; 20(11):5921-5936. PubMed ID: 37874541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
    Shi L; Gu H
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical development of immunotherapy for prostate cancer.
    Noguchi M; Koga N; Igawa T; Itoh K
    Int J Urol; 2017 Sep; 24(9):675-680. PubMed ID: 28636142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKCζ in prostate cancer cells represses the recruitment and M2 polarization of macrophages in the prostate cancer microenvironment.
    Fan HH; Li L; Zhang YM; Yang J; Li MC; Zeng FY; Deng F
    Tumour Biol; 2017 Jun; 39(6):1010428317701442. PubMed ID: 28631559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron chelated melanin-like nanoparticles for tumor-associated macrophage repolarization and cancer therapy.
    Rong L; Zhang Y; Li WS; Su Z; Fadhil JI; Zhang C
    Biomaterials; 2019 Dec; 225():119515. PubMed ID: 31590119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression.
    Liang P; Henning SM; Schokrpur S; Wu L; Doan N; Said J; Grogan T; Elashoff D; Cohen P; Aronson WJ
    Prostate; 2016 Oct; 76(14):1293-302. PubMed ID: 27338236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.